Isis Pharmaceuticals Inc

This profile gathers the share dealings of Isis Pharmaceuticals Inc in Regulus Therapeutics Inc. We count 73 filings; the first trade dates from 10 October 2012 and the latest from 17 July 2015.

The open-market side counts 1 purchase for €2.3M alongside 70 sales for €23.0M. Netting one side against the other leaves €20.7M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2015 to date brings no purchases and 4 sales.

The record was last updated on 17 July 2015 with an open-market sale (€640k) in Regulus Therapeutics Inc. The most recent open-market purchase was published on 11 October 2012, 5,141 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.